Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming

Fan Zhang,Chuanlin Ding,Diego Elias Montoya-Durango,Xiaoling Hu,Chenghui Yang,Zhen Wang,Fang Yuan,Matthew Fox,Haixun Guo,David Tieri,Maiying Kong,Xiang Zhang,Jian Huang,Jun Yan,Samantha M. Morrissey,Huang-ge Zhang,Corey T. Watson,Robert A. Mitchell,Kelly M. McMasters

DOI: https://doi.org/10.1016/j.cmet.2021.09.002

IF: 29

2021-10-01

Cell Metabolism

Abstract:One of the defining characteristics of a pre-metastatic niche, a fundamental requirement for primary tumor metastasis, is infiltration of immunosuppressive macrophages. How these macrophages acquire their phenotype remains largely unexplored. Here, we demonstrate that tumor-derived exosomes (TDEs) polarize macrophages toward an immunosuppressive phenotype characterized by increased PD-L1 expression through NF-kB-dependent, glycolytic-dominant metabolic reprogramming. TDE signaling through TLR2 and NF-κB leads to increased glucose uptake. TDEs also stimulate elevated NOS2, which inhibits mitochondrial oxidative phosphorylation resulting in increased conversion of pyruvate to lactate. Lactate feeds back on NF-κB, further increasing PD-L1. Analysis of metastasis-negative lymph nodes of non-small-cell lung cancer patients revealed that macrophage PD-L1 positively correlates with levels of GLUT-1 and vesicle release gene YKT6 from primary tumors. Collectively, our study provides a novel mechanism by which macrophages within a pre-metastatic niche acquire their immunosuppressive phenotype and identifies an important link among exosomes, metabolism, and metastasis.

cell biology,endocrinology & metabolism